Holderness Investments CO Merck & Co., Inc. Transaction History

Holderness Investments CO

$461 Million
Q2 2025

A detailed history of Holderness Investments CO transactions in Merck & Co., Inc. stock. As of the latest transaction made, Holderness Investments CO holds 35,271 shares of MRK stock, worth $2.96 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares

35,271

Previous 45,017 21.65%

Holding current value

$2.96 Million

Previous $4.04 Million 30.89%

% of portfolio

0.61%

Previous 0.95%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	SELL	$73.47 - $87.12 $716,038 - $849,071	-9,746 Reduced 21.65%	35,271 $2.79 Million
Q1 2025 May 13, 2025	SELL	$83.01 - $101.02 $17,681 - $21,517	-213 Reduced 0.47%	45,017 $4.04 Million
Q4 2024 Feb 11, 2025	SELL	$96.31 - $114.76 $168,927 - $201,289	-1,754 Reduced 3.73%	45,230 $4.5 Million
Q3 2024 Nov 12, 2024	BUY	$111.15 - $128.97 $2,667 - $3,095	24 Added 0.05%	46,984 $5.34 Million
Q2 2024 Aug 13, 2024	SELL	$123.8 - $132.96 $23,645 - $25,395	-191 Reduced 0.41%	46,960 $5.81 Million
Q1 2024 May 13, 2024	SELL	$113.24 - $131.95 $8,266 - $9,632	-73 Reduced 0.15%	47,151 $6.22 Million
Q4 2023 Feb 13, 2024	BUY	$100.18 - $109.02 $1.1 Million - $1.2 Million	11,022 Added 30.45%	47,224 $5.15 Million
Q3 2023 Nov 15, 2023	SELL	$102.95 - $114.33 $29,031 - $32,241	-282 Reduced 0.77%	36,202 $3.73 Million
Q2 2023 Aug 15, 2023	BUY	$108.61 - $118.38 $148,578 - $161,943	1,368 Added 3.9%	36,484 $4.21 Million
Q1 2023 May 12, 2023	BUY	$102.94 - $114.86 $60,322 - $67,307	586 Added 1.7%	35,116 $3.74 Million
Q4 2022 Feb 13, 2023	SELL	$87.44 - $112.11 $41,009 - $52,579	-469 Reduced 1.34%	34,530 $3.83 Million
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $32,882 - $36,939	-389 Reduced 1.1%	34,999 $3.01 Million
Q2 2022 Aug 15, 2022	SELL	$83.49 - $94.64 $55,771 - $63,219	-668 Reduced 1.85%	35,388 $3.23 Million
Q1 2022 May 12, 2022	BUY	$73.51 - $82.4 $36,093 - $40,458	491 Added 1.38%	36,056 $2.96 Million
Q4 2021 Feb 09, 2022	BUY	$72.28 - $90.54 $55,800 - $69,896	772 Added 2.22%	35,565 $2.73 Million
Q3 2021 Nov 12, 2021	BUY	$71.68 - $78.83 $1,075 - $1,182	15 Added 0.04%	34,793 $2.61 Million
Q2 2021 Aug 09, 2021	BUY	$70.31 - $77.77 $77,130 - $85,313	1,097 Added 3.26%	34,778 $2.71 Million
Q1 2021 May 11, 2021	SELL	$68.86 - $81.11 $13,703 - $16,140	-199 Reduced 0.59%	33,681 $2.6 Million
Q4 2020 Feb 05, 2021	SELL	$71.77 - $79.65 $56,698 - $62,923	-790 Reduced 2.28%	33,880 $2.77 Million
Q3 2020 Nov 09, 2020	BUY	$73.18 - $82.95 $330,480 - $374,602	4,516 Added 14.98%	34,670 $2.88 Million
Q2 2020 Aug 13, 2020	BUY	$70.42 - $80.13 $142,037 - $161,622	2,017 Added 7.17%	30,154 $2.33 Million
Q1 2020 May 13, 2020	SELL	$63.36 - $87.82 $73,370 - $101,695	-1,158 Reduced 3.95%	28,137 $2.17 Million
Q4 2019 Feb 05, 2020	SELL	$77.58 - $87.54 $38,634 - $43,594	-498 Reduced 1.67%	29,295 $2.66 Million
Q3 2019 Nov 01, 2019	SELL	$76.08 - $82.93 $2,967 - $3,234	-39 Reduced 0.13%	29,793 $2.51 Million
Q2 2019 Aug 02, 2019	BUY	$69.84 - $81.59 $75,147 - $87,790	1,076 Added 3.74%	29,832 $2.5 Million
Q1 2019 May 20, 2019	SELL	$69.58 - $79.36 $2,922 - $3,333	-42 Reduced 0.15%	28,756 $2.39 Million
Q4 2018 Feb 13, 2019	BUY	$65.24 - $75.71 $25,247 - $29,299	387 Added 1.36%	28,798 $2.2 Million
Q3 2018 Nov 13, 2018	BUY	$57.69 - $67.84 $48,632 - $57,189	843 Added 3.06%	28,411 $2.02 Million
Q2 2018 Aug 16, 2018	SELL	$50.83 - $59.72 $1,423 - $1,672	-28 Reduced 0.1%	27,568 $1.67 Million
Q1 2018 May 10, 2018	BUY	$50.96 - $59.23 $100,493 - $116,801	1,972 Added 7.7%	27,596 $1.5 Million
Q4 2017 Feb 13, 2018	BUY	$51.62 - $61.64 $7,484 - $8,937	145 Added 0.57%	25,624 $1.44 Million
Q3 2017 Nov 09, 2017	BUY	$58.67 - $63.13 $1.49 Million - $1.61 Million	25,479	25,479 $1.63 Million

Others Institutions Holding MRK

# of Institutions

3,849

Shares Held

1.96B

Call Options Held

29.2M

Put Options Held

30M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $213B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Holderness Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Holderness Investments CO with notifications on news.

Account

Holderness Investments CO Merck & Co., Inc. Transaction History